← board
NATR
distress 0/10 · well-funded / low risk$20.42-2%today-27% from 52w high
Revenue
$123M
Liquidity
$88M
Runway
—
Shares 1y
+1%
Price & events
-16.8% over 6M
CatalystRating changeDilutionFinancingdashed = today
-1.9%
1D
-4.3%
1W
-1.8%
1M
-24.0%
3M
-17.2%
6M
+34.3%
1Y
+25.5%
2Y
+15.6%
5Y
+49.0%
All
Overview
- Market Cap
- $359.08M
- Volume
- 12.68K
- 52 Week Range
- $13.14 – $27.80
- Total Shares
- 17.58M
- Float Shares
- 12.69M
- Short %
- 4.88%
- % Held by Insiders
- 3.07%
- % Held by Institutions
- 88.22%
- RVOL
- 0.11x
- Beta
- 0.87
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-07-30earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- 2026-05-11DA DavidsonBuy
- 2026-03-12DA DavidsonBuy
- 2026-03-11Canaccord GenuityBuy
- 2026-03-10Canaccord GenuityBuy
- 2025-11-10DA DavidsonBuy
- 2025-08-01Canaccord GenuityBuy
Competitors
- none identified
Recent news
- 2026-06-15Natures Sunshine (NATR) EVP sells 2,000 shares in open-market trades - Stock Titan
- 2026-06-08How The Story Around Nature’s Sunshine (NATR) Is Shifting After Q4 And New Analyst Targets - Yahoo Finance
- 2026-06-03Natures Sunshine Products (NATR) EVP sells 9,713 shares, holds 47,276 - Stock Titan
- 2026-05-11Results: Nature's Sunshine Products, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st
- 2026-05-11NATR Q1 Deep Dive: Digital Channel Expansion and Margin Gains Shape Outlook - Yahoo Finance
- 2026-05-07Nature's Sunshine Products, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
- 2026-03-11NATR: Canaccord Genuity Raises Price Target to $33.00, Maintains Buy Rating | NATR Stock News - GuruFocus
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.